Status:
UNKNOWN
A Non-Randomized Study of Internal Radiation Therapy to the Liver in Patients With Primary Liver Cancer for Whom Surgery is Not Possible.
Lead Sponsor:
St. Joseph's Hospital, Florida
Conditions:
Liver Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Surgical resection of the affected liver offers the best chance for disease-free survival in patients with Hepatoma (HCC). Unfortunately, most hepatoma patients present with disease which is multi-foc...
Detailed Description
Protocol Objectives include: * Determine the proportion of patients with HCC in whom the treatment plan can be completed * Evaluate the response to therapy * Evaluate toxicities and adverse experienc...
Eligibility Criteria
Inclusion
- Over 18 years of age of any sex, race
- Histological proof of HCC
- Able to give Informed Consent
- ECOG performance equal or less than 2
- Life expectancy equal to or greater than 3 months
- Non- pregnant with acceptable contraception in premenopausal women
- Greater than 4 weeks since prior radiation therapy or surgery
- 1 month post chemotherapy
- Serum Bilirubin \< 2.0
- Acceptable white blood count
Exclusion
- Co-morbid disease that would place patient at undue risk.
- Pre-existing diarrhea/illness
- Pregnant
- Fail preliminary MAA testing
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
End Date :
June 1 2005
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00152087
Start Date
October 1 2002
End Date
June 1 2005
Last Update
September 9 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Joseph's Hospital
Tampa, Florida, United States, 33607